Related Experiment Video
Updated: Aug 17, 2026
An In Vitro Skin Irritation Test (SIT) using the EpiDerm Reconstructed Human Epidermal (RHE) Model
Published on: July 13, 2009
Laboratory evaluation of the child with recalcitrant eczema
1Department of Dermatology, University of Texas-Houston Medical School.
Insights
When a child's eczema doesn't improve with standard treatment, consider other diagnoses like infections, psoriasis, or immune disorders. This guide helps evaluate nonresponsive eczema cases in children.
Area of Science:
- Pediatric Dermatology
- Immunology
- Genetics
Background:
- Eczema is a common skin condition in children.
- Nonresponsive eczema presents a diagnostic challenge.
- Identifying underlying causes is crucial for effective management.
Purpose of the Study:
- To outline differential diagnoses for nonresponsive pediatric eczema.
- To guide diagnostic and laboratory evaluations.
- To provide a framework for managing complex eczema cases.
Main Methods:
- Literature review of common and rare causes of nonresponsive eczema.
- Discussion of diagnostic criteria for various conditions.
- Overview of relevant laboratory and clinical evaluations.
Main Results:
- Common considerations include infectious/parasitic disorders, psoriasis, and heritable conditions.
- Langerhans cell histiocytosis and immune-related syndromes are also important differentials.
- A systematic approach aids in identifying the correct diagnosis.
Conclusions:
- Nonresponsive eczema warrants a broad differential diagnosis.
- Systematic evaluation is key to successful treatment.
- This guide assists clinicians in managing challenging pediatric eczema cases.
Abstract:
This article discusses many of the more common diagnoses that should be considered when managing a child with nonresponsive excema. Some of these possible diagnoses are infectious and parasitic disorders, psoriasis, heritable disorders, Langerhans cell histiocytosis, and syndromes with altered immunity and eczematous skin changes. This overview of diagnostic and laboratory evaluations of the child with eczema who fails standard therapy is presented as a useful guide in evaluating these patients.
